サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421594

医薬品賦形剤市場、シェア、規模、動向、産業分析レポート：製品別、製剤別、機能性別、地域別、セグメント別予測、2023年～2032年

Pharmaceutical Excipients Market Share, Size, Trends, Industry Analysis Report, By Product (Inorganic Chemicals, Organic Chemicals); By Formulation; By Functionality; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品賦形剤市場、シェア、規模、動向、産業分析レポート：製品別、製剤別、機能性別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の医薬品賦形剤市場規模は2032年までに167億9,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

医薬品賦形剤は医薬品製剤に配合されるが、その主な目的は治療効果ではなく、製造プロセスの合理化、製品の保護、安定性の向上、バイオアベイラビリティの改善、患者の受容性の確保です。さらに、製品の識別に貢献し、保管中や使用中の製品の安全性と機能性を維持する上で重要な役割を果たすこともあります。

医薬品賦形剤は、医薬品投与プロセスの最適化、投与レジメンの順守の促進、一貫性の保持、活性医薬成分の安定化、薬物吸収の調節、最終製品の信頼性と均一性の保証に不可欠です。

研究開発（R&D）への投資の急増が市場の拡大を後押ししています。製薬会社は、より効率的で安全な医薬品を開発するための研究開発プロジェクトに多大な資源を投入しています。賦形剤は、この過程で医薬製剤の有効性と安全性を高めるために不可欠です。研究開発費が増加し続けるにつれ、革新的で高品質な賦形剤へのニーズが高まることが予想されます。

COVID-19パンデミックの広範囲に及ぶ結果、医薬品セクターは大きな変化を経験しました。パンデミックの発生に対応するために閉鎖措置がとられたため、インドや中国などの主要生産拠点から入手した重要な原材料の流れが途絶えました。その結果、この混乱は医薬品の研究や製造手順の進歩に悪影響を及ぼし、特に外部サプライヤーへの依存度が高い企業に影響を与えました。パンデミックは当初、製薬業界全体に大きな混乱をもたらしました。

COVID-19パンデミックの間、製薬会社やバイオテクノロジー企業は、治療薬、ワクチン、科学的アプローチの考案において、驚くべき回復力と創意工夫を発揮しました。さらに、規制当局は、医薬品による治療を受ける患者の幸福を保証するために、新たなガイドラインを再評価し、実施するよう促されました。

さらに、2021年6月にNational Library of Medicineに掲載された研究では、冠動脈疾患（CAD）が世界の健康に与える影響の大きさが強調されました。CADだけで年間約61万人が死亡しており、推定死亡者数の4人に1人を占め、米国における死亡原因の第1位となっています。CADの発症率が上昇するにつれ、この差し迫った医療ニーズに対処するための効果的な冠動脈ステント装置に対する需要が高まっています。その結果、この要因が予測期間を通じて冠動脈ステントの需要を促進すると予測されています。

医薬品賦形剤市場レポートハイライト

  • 2022年、医薬品賦形剤市場では有機化学品分野が最大の収益シェアを占めました。世界の医薬品賦形剤市場は、主に医薬品製剤に使用される化合物の普及により、今後数年間で大幅な拡大が見込まれています。この成長を支えているのは、天然資源に依存し、副作用を最小限に抑えた医薬品製造に対する需要の高まりです。さらに、ライフサイエンス業界ではHPMC有機化合物の利用が急増しており、この特定分野の成長をさらに後押ししています。また、固形経口剤への誘導体の広範な採用や、世界のジェネリック製品開発の継続的な進歩といった要因からも、この市場は利益を得ることができます。
  • 予測期間中、市場セグメンテーションは最大の市場シェアを占めました。結合剤賦形剤は、粉末、顆粒、その他の乾燥成分を効果的に結合させ、医薬品に構造的な完全性を与える不可欠な接着剤として機能することにより、医薬品製剤において極めて重要な役割を果たしています。さらに、これらの賦形剤は、薬物の体積を増大させ、崩壊を促進し、溶解速度を速めることにより、医薬製剤において重要な役割を担っています。その結果、製薬業界では医薬品や医薬品の製造において、これらの賦形剤の需要が高まっています。病気や病状の蔓延が続く中、薬や治療に対するニーズが高まっています。このような医薬品需要の増加により、医療用医薬品の製造に不可欠な結合剤賦形剤への要求が高まっています。このことが、今後数年間の市場成長の原動力になると予想されます。
  • 2022年には、アジア太平洋が最大の市場を占めました。最近の調査によると、中国の伝統的製薬産業の売上高は約288億米ドルでした。この分野は、当面の間、継続的な成長が見込まれています。また、インドは世界の医薬品業界において重要な地位を占めており、世界のワクチンの50％以上、米国のジェネリック医薬品供給の40％、英国の全医薬品の25％を供給しています。さらに、インドは世界第2位の製薬・バイオテクノロジー労働力を誇っています。2021年のインド経済調査によると、国内の医薬品市場は今後10年間で3倍の規模になると予想されています。
  • 医薬品賦形剤市場において最も急成長を遂げたのは欧州地域です。同地域では現在、賦形剤の使用が大幅に増加しています。この急成長の主な要因は、広範な製造能力を備えた大手製薬会社の出現です。さらに、これにより革新的な賦形剤成分への要求が高まり、賦形剤需要を牽引しています。製薬業界は、先端医薬品、ジェネリック医薬品、バイオシミラー製品への依存度を高めています。
  • いくつかの要因がこの市場に影響を与えています。新薬の開発、ジェネリック医薬品の拡大、患者にやさしい製剤の重視などです。このような製剤には、経口溶解錠や味をマスキングするように設計された賦形剤などがあります。このような状況において、欧州医薬品庁（EMA）が製品の安全性と規制遵守を確保する上で重要な役割を果たしていることは注目に値します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の医薬品賦形剤市場に関する洞察

  • 医薬品賦形剤市場- 機能スナップショット
  • 医薬品賦形剤市場力学
    • 促進要因と機会
      • 世界中で医薬品の摂取量が増加すると市場の成長が促進される
      • 添加剤の需要の増加が市場の成長を促進する
    • 抑制要因と課題
      • 添加剤および医薬品の承認に関する規制の厳しさの急増
  • PESTEL分析
  • 医薬品賦形剤市場の機能動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の医薬品賦形剤市場、製剤別

  • 主な調査結果
  • イントロダクション
  • 錠剤製剤
  • カプセル製剤
  • 静脈製剤
  • 液体製剤
  • 経口製剤

第6章 世界の医薬品賦形剤市場、製品別

  • 主な調査結果
  • イントロダクション
  • 無機化学薬品
  • 有機化学品

第7章 世界の医薬品賦形剤市場、機能別

  • 主な調査結果
  • イントロダクション
  • バインダー
  • 充填剤と希釈剤
  • 懸濁剤および増粘剤
  • 防腐剤
  • 香料および甘味料
  • コーティング剤

第8章 世界の医薬品賦形剤市場、地域別

  • 主な調査結果
  • イントロダクション
    • 医薬品賦形剤市場評価、地域別、2019-2032年
  • 医薬品賦形剤市場-北米
    • 北米：医薬品賦形剤市場、製剤別、2019-2032年
    • 北米：医薬品賦形剤市場、機能別、2019-2032年
    • 北米：医薬品賦形剤市場、製品別、2019-2032年
    • 医薬品賦形剤市場-米国
    • 医薬品賦形剤市場- カナダ
  • 医薬品賦形剤市場- 欧州
    • 欧州：医薬品賦形剤市場、製剤別、2019～2032年
    • 欧州：医薬品賦形剤市場、機能別、2019-2032
    • 欧州：医薬品賦形剤市場、製品別、2019～2032年
    • 医薬品賦形剤市場- 英国
    • 医薬品賦形剤市場- フランス
    • 医薬品賦形剤市場- ドイツ
    • 医薬品賦形剤市場- イタリア
    • 医薬品賦形剤市場- スペイン
    • 医薬品賦形剤市場- オランダ
    • 医薬品賦形剤市場- ロシア
  • 医薬品賦形剤市場- アジア太平洋
    • アジア太平洋：医薬品賦形剤市場、製剤別、2019～2032年
    • アジア太平洋：医薬品賦形剤市場、機能別、2019～2032年
    • アジア太平洋：医薬品賦形剤市場、製品別、2019-2032年
    • 医薬品賦形剤市場- 中国
    • 医薬品賦形剤市場- インド
    • 医薬品賦形剤市場- マレーシア
    • 医薬品賦形剤市場- 日本
    • 医薬品賦形剤市場- インドネシア
    • 医薬品賦形剤市場- 韓国
  • 医薬品賦形剤市場-中東およびアフリカ
    • 中東およびアフリカ：医薬品賦形剤市場、製剤別、2019-2032年
    • 中東およびアフリカ：医薬品賦形剤市場、機能別、2019～2032年
    • 中東およびアフリカ：医薬品賦形剤市場、製品別、2019-2032年
    • 医薬品賦形剤市場- サウジアラビア
    • 医薬品賦形剤市場- アラブ首長国連邦
    • 医薬品賦形剤市場- イスラエル
    • 医薬品賦形剤市場- 南アフリカ
  • 医薬品賦形剤市場-ラテンアメリカ
    • ラテンアメリカ：医薬品賦形剤市場、製剤別、2019-2032年
    • ラテンアメリカ：医薬品賦形剤市場、機能別、2019-2032
    • ラテンアメリカ：医薬品賦形剤市場、製品別、2019-2032年
    • 医薬品賦形剤市場- メキシコ
    • 医薬品賦形剤市場- ブラジル
    • 医薬品賦形剤市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Ashland Inc.
  • Associated British Foods Plc
  • BASF SE
  • Croda International Inc.
  • DOW Chemical Company
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • FMG Corporation
  • Innophos Holdings Inc.
  • Lubrizol Corporation
  • MEGGLE Excipients & Technology
  • Roquette Group
図表

List of Tables

  • Table 1 Global Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 2 Global Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 4 Pharmaceutical Excipients Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 6 North America: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 8 U.S.: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 9 U.S.: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 11 Canada: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 12 Canada: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 14 Europe: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 15 Europe: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 17 UK: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 18 UK: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 20 France: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 21 France: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 23 Germany: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 24 Germany: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 26 Italy: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 27 Italy: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 29 Spain: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 30 Spain: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 35 Russia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 36 Russia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 41 China: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 42 China: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 44 India: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 45 India: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 50 Japan: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 51 Japan: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 56 South Korea: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 57 South Korea: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 65 UAE: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 66 UAE: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 68 Israel: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 69 Israel: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 71 South Africa: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 72 South Africa: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 74 Latin America: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 75 Latin America: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 77 Mexico: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 78 Mexico: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 80 Brazil: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 81 Brazil: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • Table 83 Argentina: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • Table 84 Argentina: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Pharmaceutical Excipients Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Pharmaceutical Excipients Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Formulation
  • Figure 9. Global Pharmaceutical Excipients Market, by Formulation, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Functionality
  • Figure 11. Global Pharmaceutical Excipients Market, by Functionality, 2022 & 2032 (USD Billion)
  • Figure 12. Pharmaceutical Excipients Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Pharmaceutical Excipients Market
目次
Product Code: PM3919

The global pharmaceutical excipients market size is expected to reach USD 16.79 Billion by 2032, according to a new study by Polaris Market Research. The report "Pharmaceutical Excipients Market Share, Size, Trends, Industry Analysis Report, By Product (Inorganic Chemicals, Organic Chemicals); By Formulation; By Functionality; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical excipients are included in pharmaceutical formulations not primarily for their therapeutic benefits but instead to streamline the manufacturing process, safeguard the product, enhance its stability, improve bioavailability, and ensure patient acceptance. Furthermore, they can contribute to product identification and play a crucial role in maintaining the product's safety and functionality during storage and use.

Pharmaceutical excipients are essential for optimizing the drug administration process, fostering adherence to dosing regimens, preserving consistency, stabilizing active pharmaceutical components, modulating drug absorption, and guaranteeing the dependability and uniformity of the end product.

Surging levels of investment in research and development (R&D) are propelling the expansion of the market. Pharmaceutical companies are dedicating significant resources to R&D projects focused on creating medications that are both more efficient and safer. Excipients are essential in enhancing the effectiveness and safety of medication formulations during this process. As R&D spending continues to increase, there is an expected growth in the need for innovative and high-quality excipients.

The pharmaceutical sector experienced substantial changes as a result of the far-reaching consequences of the COVID-19 pandemic. The imposition of lockdowns in response to the outbreak disrupted the flow of crucial raw materials obtained from major production centers such as India and China. As a result, this disruption had a negative impact on the advancement of drug research and production procedures, especially affecting companies that heavily depend on external suppliers. In the beginning, the pandemic caused significant turmoil throughout the pharmaceutical industry as a whole.

During the COVID-19 pandemic, pharmaceutical and biotech companies exhibited remarkable resilience and ingenuity in crafting therapeutics, vaccines, and scientific approaches. Additionally, regulatory agencies were prompted to reevaluate and implement new guidelines to guarantee the well-being of patients using pharmaceutical treatments.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.

Pharmaceutical Excipients Market Report Highlights

  • In 2022, the Organic Chemicals segment held the largest revenue share in the Pharmaceutical Excipients Market. The Global Pharmaceutical Excipients Market is poised for substantial expansion in the coming years, primarily due to the prevalence of compounds used in pharmaceutical formulations. This growth is underpinned by the increasing demand for drug manufacturing that relies on natural resources and minimizes adverse side effects. Furthermore, the life sciences industry is witnessing a surge in the utilization of HPMC organic compounds, further propelling the growth of this specific sector. The market also stands to gain from factors like the widespread adoption of derivatives in solid oral dosage forms and the continual advancements in global generic product development.
  • The Blinders segment accounted for the largest market share during the forecast period. Binder excipients play a pivotal role in pharmaceutical formulations by acting as essential adhesives, effectively uniting powders, granules, and other dry components to provide structural integrity to pharmaceutical products. Moreover, these excipients hold significant importance in drug formulation by augmenting drug volume, promoting disintegration, and expediting dissolution rates. Consequently, the pharmaceutical industry is experiencing a growing demand for these excipients in the manufacturing of drugs and medicines. As the prevalence of illnesses and medical conditions continues to rise, there is an amplified need for medications and treatments. This increased demand for pharmaceuticals is creating a higher requirement for binder excipients that are indispensable in the production of medical drugs. This, in turn, is expected to be a driving force behind market growth in the coming years.
  • In 2022, Asia-Pacific dominated the largest market. A recent study reveals that the traditional pharmaceutical industry in China generated approximately $28.8 billion in sales revenue. This sector is poised for continued growth in the foreseeable future. India also holds a prominent position in the global pharmaceutical landscape, serving as the source of over 50% of the world's vaccines, 40% of the United States' generic drug supply, and 25% of all medications for the United Kingdom, particularly during the ongoing COVID-19 pandemic. Furthermore, India boasts the world's second-largest pharmaceutical and biotech workforce. According to the Indian Economic Survey of 2021, the domestic pharmaceutical market is expected to triple in size over the next decade.
  • The Europe region accounted for the fastest growth in the Pharmaceuticals Excipients Market. The region is currently witnessing a substantial increase in the use of excipients. This surge can be attributed primarily to the emergence of major pharmaceutical giants equipped with extensive manufacturing capabilities. Furthermore, this heightened the growing requirement for innovative excipient components, which drives demand for excipients. The pharmaceutical industry is increasingly reliant on advanced pharmaceutical drugs, generic medications, and biosimilar products.
  • Several factors have influenced this market. These include the ongoing development of new drugs, the expansion of the generic drug sector, and a notable emphasis on patient-friendly formulations. Such formulations include oral dissolvable tablets and excipients designed to mask taste. It's worth noting that the European Medicines Agency (EMA) plays a crucial role in ensuring product safety and regulatory compliance within this context.
  • The global key market players include: Ashland Inc., Associated British Foods Plc, BASF SE, Croda International Inc., DOW Chemical Company, DuPont de Nemours Inc., Evonik Industries AG, FMG Corporation, Innophos Holdings Inc., Lubrizol Corporation, MEGGLE Excipients & Technology, and Roquette Group

Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, functionality, and region:

Pharmaceutical Excipients, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inorganic Chemicals
  • Organic Chemicals

Pharmaceuticals Excipients, Formulation Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablets Formulation
  • Capsules Formulation
  • Parental Formulation
  • Liquid Formulation
  • Oral Formulation

Pharmaceutical Excipients, Functionality Outlook (Revenue - USD Billion, 2019 - 2032)

  • Blinders
  • Fillers & Diluents
  • Suspending & Viscosity agents
  • Preservatives
  • Flavoring agents & Sweeteners
  • Coating agents

Coronary Stent, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pharmaceutical Excipients Market Insights

  • 4.1. Pharmaceutical Excipients Market - Functionality Snapshot
  • 4.2. Pharmaceutical Excipients Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing intake of pharmaceutical products across the Globe will facilitate market growth
      • 4.2.1.2. Rise in the demand for Excipients will boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Surging Regulatory stringency concerning the approval of Excipients and Drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Pharmaceutical Excipients Market Functionality Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pharmaceutical Excipients Market, by Formulation

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
  • 5.3. Tablets Formulation
    • 5.3.1. Global Pharmaceutical Excipients Market, by Tablets Formulation, by Region, 2019-2032 (USD Billion)
  • 5.4. Capsules Formulation
    • 5.4.1. Global Pharmaceutical Excipients Market, by Capsules Formulation, by Region, 2019-2032 (USD Billion)
  • 5.5. Parental Formulation
    • 5.5.1. Global Pharmaceutical Excipients Market, by Parental Formulation, by Region, 2019-2032 (USD Billion)
  • 5.6. Liquid Formulation
    • 5.6.1. Global Pharmaceutical Excipients Market, by Liquid Formulation, by Region, 2019-2032 (USD Billion)
  • 5.7. Oral Formulation
    • 5.7.1. Global Pharmaceutical Excipients Market, by Oral Formulation, by Region, 2019-2032 (USD Billion)

6. Global Pharmaceutical Excipients Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Inorganic Chemicals
    • 6.3.1. Global Pharmaceutical Excipients Market, by Inorganic Chemicals, by Region, 2019-2032 (USD Billion)
  • 6.4. Organic Chemicals
    • 6.4.1. Global Pharmaceutical Excipients Market, by Organic Chemicals, by Region, 2019-2032 (USD Billion)

7. Global Pharmaceutical Excipients Market, by Functionality

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
  • 7.3. Binders
    • 7.3.1. Global Pharmaceutical Excipients Market, by Binders, By Region, 2019-2032 (USD Billion)
  • 7.4. Fillers & Diluents
    • 7.4.1. Global Pharmaceutical Excipients Market, by Fillers & Diluents, By Region, 2019-2032 (USD Billion)
  • 7.5. Suspending & Viscosity Agents
    • 7.5.1. Global Pharmaceutical Excipients Market, by Suspending & Viscosity Agents, By Region, 2019-2032 (USD Billion)
  • 7.6. Preservatives
    • 7.6.1. Global Pharmaceutical Excipients Market, by Preservatives, By Region, 2019-2032 (USD Billion)
  • 7.7. Flavoring agents & Sweeteners
    • 7.7.1. Global Pharmaceutical Excipients Market, by Flavoring agents & Sweeteners, By Region, 2019-2032 (USD Billion)
  • 7.8. Coating agents
    • 7.8.1. Global Pharmaceutical Excipients Market, by Coating agents, By Region, 2019-2032 (USD Billion)

8. Global Pharmaceutical Excipients Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Pharmaceutical Excipients Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Pharmaceutical Excipients Market - North America
    • 8.3.1. North America: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
    • 8.3.2. North America: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
    • 8.3.3. North America: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Pharmaceutical Excipients Market - U.S.
      • 8.3.4.1. U.S.: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Pharmaceutical Excipients Market - Canada
      • 8.3.5.1. Canada: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Pharmaceutical Excipients Market - Europe
    • 8.4.1. Europe: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Pharmaceutical Excipients Market - UK
      • 8.4.4.1. UK: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Pharmaceutical Excipients Market - France
      • 8.4.5.1. France: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Pharmaceutical Excipients Market - Germany
      • 8.4.6.1. Germany: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Pharmaceutical Excipients Market - Italy
      • 8.4.7.1. Italy: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Pharmaceutical Excipients Market - Spain
      • 8.4.8.1. Spain: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Pharmaceutical Excipients Market - Netherlands
      • 8.4.9.1. Netherlands: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Pharmaceutical Excipients Market - Russia
      • 8.4.10.1. Russia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Pharmaceutical Excipients Market - Asia Pacific
    • 8.5.1. Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Pharmaceutical Excipients Market - China
      • 8.5.4.1. China: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Pharmaceutical Excipients Market - India
      • 8.5.5.1. India: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Pharmaceutical Excipients Market - Malaysia
      • 8.5.6.1. Malaysia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Pharmaceutical Excipients Market - Japan
      • 8.5.7.1. Japan: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Pharmaceutical Excipients Market - Indonesia
      • 8.5.8.1. Indonesia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Pharmaceutical Excipients Market - South Korea
      • 8.5.9.1. South Korea: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Pharmaceutical Excipients Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Pharmaceutical Excipients Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Pharmaceutical Excipients Market - UAE
      • 8.6.5.1. UAE: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Pharmaceutical Excipients Market - Israel
      • 8.6.6.1. Israel: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Pharmaceutical Excipients Market - South Africa
      • 8.6.7.1. South Africa: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Pharmaceutical Excipients Market - Latin America
    • 8.7.1. Latin America: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Pharmaceutical Excipients Market - Mexico
      • 8.7.4.1. Mexico: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Pharmaceutical Excipients Market - Brazil
      • 8.7.5.1. Brazil: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Pharmaceutical Excipients Market - Argentina
      • 8.7.6.1. Argentina: Pharmaceutical Excipients Market, by Formulation, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Pharmaceutical Excipients Market, by Functionality, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Pharmaceutical Excipients Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Ashland Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Associated British Foods Plc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BASF SE
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Croda International Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DOW Chemical Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. DuPont de Nemours Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Evonik Industries AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. FMG Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Innophos Holdings Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Lubrizol Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. MEGGLE Excipients & Technology
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Roquette Group
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development